Advertisement
Individuals with the healthiest lifestyle have a 75 percent reduced risk for type 2 diabetes

T2DM Risk Reduced by 75 Percent With Healthiest Lifestyle

0
Risk for all-cause, CVD, cancer mortality lower with healthiest lifestyle for those with type 2 diabetes
Among medical school matriculants

Racial, Ethnic Underrepresentation Found in Med School Matriculants

0
Black, Hispanic, American Indian or Alaska Native students underrepresented versus U.S. population
In updated guidelines developed by the European Society of Cardiology

ESC Guidelines Updated for Managing CVD in Diabetes

0
Guidelines address lifestyle recommendations, individualized BP targets, SGLT2 inhibitor, GLP1-RA tx
Menstrual cycle length per woman is varied

Menstrual Cycles More Varied Than Previously Thought

0
Tracking basal body temperature and other parameters improves accuracy of ovulation detection
Testosterone can be used for postmenopausal women with hypoactive sexual desire dysfunction but is not recommended for other symptoms or medical conditions

Position Statement Clarifies Benefits of Testosterone Therapy for Women

0
Testosterone only recommended for postmenopausal women with hypoactive sexual desire dysfunction
Sixty percent of U.S. physicians believe that the Affordable Care Act has improved access to care and insurance after five years of implementation

Majority of U.S. Doctors Believe ACA Has Improved Access to Care

0
In 2017 versus 2012, more doctors agreed the ACA would turn U.S. health care in the right direction
For patients with type 2 diabetes and obesity

Metabolic Surgery May Reduce CV Risk in T2DM With Obesity

0
Reduction seen in primary end point and seven prespecified secondary outcomes, including mortality
Greater consumption of soft drinks

Drinking Soft Drinks Tied to Higher Risk for Early Death

0
Higher risk for death seen for drinking two or more sugar- or artificially sweetened soft drinks per day
A low-fat dietary pattern provides lasting health benefits

Low-Fat Dietary Pattern Offers Long-Term Health Benefits

0
Significant benefits seen in relation to breast cancer, CHD, diabetes, without adverse effects
Ticagrelor plus aspirin compared with placebo plus aspirin is associated with a lower incidence of ischemic cardiovascular events but a higher incidence of major bleeding among patients with stable coronary artery disease and type 2 diabetes

Benefit, Harm Seen for Ticagrelor Plus Aspirin in Stable CAD With T2DM

0
Incidence of ischemic cardiovascular events lower but major bleeding increased versus placebo plus aspirin